Germany · Biotechnology startup
Germany · ETHRIS
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.
Funding reportedLast round: Undisclosed round
What company datasets say ETHRIS raised
Funding, as reported
Reported in all95.4Min the source's currency
Rounds8
Last roundUndisclosed round
Last round dateJun 2024
Investors listed7
On a portfolio page
Investors who name them
Each firm lists ETHRIS on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put ETHRIS in front of investors. Or tell us what we have wrong.